BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17599039)

  • 1. Egr-1 abrogates the E2F-1 block in terminal myeloid differentiation and suppresses leukemia.
    Gibbs JD; Liebermann DA; Hoffman B
    Oncogene; 2008 Jan; 27(1):98-106. PubMed ID: 17599039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia suppressor function of Egr-1 is dependent on transforming oncogene.
    Gibbs JD; Liebermann DA; Hoffman B
    Leukemia; 2008 Oct; 22(10):1909-16. PubMed ID: 18650844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Egr-1 abrogates the block imparted by c-Myc on terminal M1 myeloid differentiation.
    Shafarenko M; Liebermann DA; Hoffman B
    Blood; 2005 Aug; 106(3):871-8. PubMed ID: 15840692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation.
    Amanullah A; Liebermann DA; Hoffman B
    Oncogene; 2000 Jun; 19(26):2967-77. PubMed ID: 10871848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
    Hoffman B; Amanullah A; Shafarenko M; Liebermann DA
    Oncogene; 2002 May; 21(21):3414-21. PubMed ID: 12032779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The zinc finger transcription factor Egr-1 activates macrophage differentiation in M1 myeloblastic leukemia cells.
    Krishnaraju K; Hoffman B; Liebermann DA
    Blood; 1998 Sep; 92(6):1957-66. PubMed ID: 9731053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulated E2F-1 blocks terminal differentiation and loss of leukemogenicity of M1 myeloblastic leukemia cells without abrogating induction of p15(INK4B) and p16(INK4A).
    Amanullah A; Hoffman B; Liebermann DA
    Blood; 2000 Jul; 96(2):475-82. PubMed ID: 10887108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibition and augmentation of mouse myeloid leukemic cell line differentiation by interleukin 1.
    Onozaki K; Tamatani T; Hashimoto T; Matsushima K
    Cancer Res; 1987 May; 47(9):2397-402. PubMed ID: 3494508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The critical role of the colony-stimulating factor-1 receptor in the differentiation of myeloblastic leukemia cells.
    Hamilton JA; Whitty G; Masendycz P; Wilson NJ; Jackson J; De Nardo D; Scholz GM
    Mol Cancer Res; 2008 Mar; 6(3):458-67. PubMed ID: 18337452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation.
    Knoepfler PS; Sykes DB; Pasillas M; Kamps MP
    Oncogene; 2001 Sep; 20(39):5440-8. PubMed ID: 11571641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 is a differentiation factor for M1 and WEHI-3B myeloid leukemic cells.
    Chiu CP; Lee F
    J Immunol; 1989 Mar; 142(6):1909-15. PubMed ID: 2784140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The early growth response factor-1 contributes to interleukin-13 production by mast cells in response to stem cell factor stimulation.
    Li B; Berman J; Wu P; Liu F; Tang JT; Lin TJ
    J Immunotoxicol; 2008 Apr; 5(2):163-71. PubMed ID: 18569387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fos modulates myeloid cell survival and differentiation and partially abrogates the c-Myc block in terminal myeloid differentiation.
    Shafarenko M; Amanullah A; Gregory B; Liebermann DA; Hoffman B
    Blood; 2004 Jun; 103(11):4259-67. PubMed ID: 14982872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
    Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
    J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of N-Myc rapidly causes acute myeloid leukemia in mice.
    Kawagoe H; Kandilci A; Kranenburg TA; Grosveld GC
    Cancer Res; 2007 Nov; 67(22):10677-85. PubMed ID: 18006809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p21Waf1 inhibits granulocytic differentiation of 32Dcl3 cells.
    Ghanem L; Steinman RA
    Leuk Res; 2006 Oct; 30(10):1285-92. PubMed ID: 16499966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early growth response-1 is involved in foam cell formation and is upregulated by the TLR9-MyD88-ERK1/2 pathway.
    Kim JS; Park DW; Lee HK; Kim JR; Baek SH
    Biochem Biophys Res Commun; 2009 Dec; 390(2):196-200. PubMed ID: 19737531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SSBP2, a candidate tumor suppressor gene, induces growth arrest and differentiation of myeloid leukemia cells.
    Liang H; Samanta S; Nagarajan L
    Oncogene; 2005 Apr; 24(16):2625-34. PubMed ID: 15782145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal myeloid differentiation is uncoupled from cell cycle arrest.
    Gibbs JD; Liebermann DA; Hoffman B
    Cell Cycle; 2007 May; 6(10):1205-9. PubMed ID: 17495532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.